Your session is about to expire
← Back to Search
GUT LINK SmartPath for Irritable Bowel Syndrome
N/A
Recruiting
Research Sponsored by Michael Stewart
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test a new set of guidelines to help doctors better diagnose and treat patients with digestive issues like IBS. The goal is to make it easier for primary care doctors to manage these conditions without needing specialists or invasive tests.
Who is the study for?
This trial is for general practitioners in Nova Scotia, Canada who use 'virtual hallway' for referrals and treat patients with lower GI complaints. It aims to improve the diagnosis and treatment of IBS by implementing a new care pathway.
What is being tested?
The GUT LINK SmartPath is being tested as a Clinical Care Pathway to help primary healthcare providers better manage lower gastrointestinal tract symptoms and differentiate IBS from more serious conditions.
What are the potential side effects?
Since this study involves the implementation of a care pathway rather than medication, traditional side effects are not applicable. However, there may be challenges or changes in practice management.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of clicks per referral
Number of referrals
Number of referrals per user
+3 moreSecondary study objectives
Number of referrals aborted
Number of referrals received requiring troubleshooting
Number referrals received as per prototype
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: GUT LINK SmartPathExperimental Treatment1 Intervention
physicians will use the interactive GUT LINK Smartpath tool in virtual hallway platform to guide their care and referral practices
Group II: controlActive Control1 Intervention
physicians will provide care and refer as per their usual practices
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for gastrointestinal disorders work through various mechanisms to alleviate symptoms. Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants help by modulating pain perception and improving mood, which can be beneficial for patients with chronic abdominal pain and overlapping symptoms of depression.
Antispasmodics, such as dicyclomine and hyoscyamine, reduce muscle spasms in the gut, providing relief from abdominal pain and discomfort. Fiber supplements like psyllium improve bowel regularity and stool consistency, which is crucial for managing constipation-predominant symptoms.
Polyethylene glycol (PEG) acts as an osmotic laxative, drawing water into the bowel to ease constipation. Bile acid sequestrants, such as cholestyramine, bind bile acids in the intestine, reducing diarrhea in patients with bile acid malabsorption.
These treatments are essential as they target specific symptoms, improving the quality of life for patients with gastrointestinal disorders.
Future aspects of functional gastrointestinal disease: how should treatments be evaluated.
Future aspects of functional gastrointestinal disease: how should treatments be evaluated.
Find a Location
Who is running the clinical trial?
Michael StewartLead Sponsor
Nova Scotia Health AuthorityOTHER
288 Previous Clinical Trials
94,442 Total Patients Enrolled
1 Trials studying Irritable Bowel Syndrome
76 Patients Enrolled for Irritable Bowel Syndrome